Jenoptik (JEN) Given a €30.00 Price Target by HSBC Analysts

Share on StockTwits

Jenoptik (ETR:JEN) has been assigned a €30.00 ($34.88) price objective by HSBC in a research note issued on Thursday. The firm currently has a “neutral” rating on the stock. HSBC’s price target suggests a potential downside of 3.60% from the company’s current price.

A number of other research analysts have also weighed in on the company. Hauck & Aufhaeuser set a €32.50 ($37.79) target price on Jenoptik and gave the stock a “buy” rating in a report on Wednesday. Warburg Research set a €33.00 ($38.37) target price on Jenoptik and gave the stock a “buy” rating in a report on Wednesday. Kepler Capital Markets set a €34.50 ($40.12) target price on Jenoptik and gave the stock a “neutral” rating in a report on Wednesday. DZ Bank reissued a “neutral” rating on shares of Jenoptik in a report on Wednesday. Finally, Baader Bank set a €30.00 ($34.88) target price on Jenoptik and gave the stock a “neutral” rating in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of €31.29 ($36.38).

JEN stock opened at €31.12 ($36.19) on Thursday. Jenoptik has a 1-year low of €20.68 ($24.05) and a 1-year high of €34.82 ($40.49).

Jenoptik Company Profile

Jenoptik AG operates as an integrated photonics company in Germany and internationally. The company's Opticals & Life Science division develops and manufactures micro-optics for beam shaping for use in the semiconductor industry, as well as for laser material processing; and optical systems and components for information and communication, security, and defense technologies.

Featured Story: Day Trading

Analyst Recommendations for Jenoptik (ETR:JEN)

Receive News & Ratings for Jenoptik Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jenoptik and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.